Aurobindo Pharma achieves record revenue in Q3 FY25 despite profit decline

Aurobindo Pharma Limited has reported its highest-ever quarterly revenue for the third quarter of fiscal year 2025, underlining its strong position in the global pharmaceutical landscape. The company’s consolidated financial results reflect an 8.5% year-on-year (YoY) increase in revenue from operations, reaching ₹7,979 crore. This growth was driven by robust performances across key mark